Metabolic syndrome (n=276) Control (n=335) p
Age, years 56.8 ± 12.2 55.6 ± 12.9 0.26
Male, n (%) 210 (76%) 311 (92%) 0.01
Height, (m) 1.69 ± 0.08 1.71 ± 0.06 0.07
Weight, (kg) 84.8 ± 13.9 77.2 ± 12.2 0.01
BMI, kg/m2 29.4 ± 4.5 26.2 ± 3.6 0.01
Smoking, n (%) 181 (66%) 273 (81%) 0.01
Hyperlipidemia, n (%) 87 (32%) 55 (16%) 0.01
Family history of CAD, n (%) 100 (36%) 91 (27%) 0.02
Prior myocardial infarction, n (%) 30 (11%) 28 (8%) 0.62
Systolic blood pressure, mmHg 125 ± 25 123 ± 24 0.15
Diastolic blood pressure, mmHg 76 ± 15 74 ± 14 0.33
Killip class >1, n (%) 15 (5%) 23 (7%) 0.46
Anterior myocardial infarction, n (%) 130 (47%) 165 (49%) 0.59
Reperfusion time, min 210 ± 130 215 ± 145 0.69
Post PCI TIMI 3 flow, n (%) 266 (96%) 330 (99%) 0.09
Left ventricular EF, % 45.1 ± 8.6 46.1 ± 8.2 0.13
Components of metabolic syndrome      
 Diabetes mellitus or fasting  glucose > 100 mg/dL, n (%) 234 (85%) 77 (23%) 0.01
 Hypertension, n (%) 184 (67%) 63 (19%) 0.01
 Waist circumference, cm 95.4 ± 12.2 88.3 ± 10.1 0.01
 HDL, cholesterol, mg/dL 37.3 ± 9.9 40.9 ± 11.3 0.01
 Triglycerides, mg/dL 181 (98) 111 (60) 0.01
 Fasting glucose level, mg/dL 121 (47) 101 (28) 0.01
Laboratory findings      
Creatinine, mg/dL 0.92 ± 0.37 0.87 ± 0.28 0.08
 Peak CK-MB, U/L 128 (140) 143 (181) 0.12
 Hemoglobin, g/dL 14.1 ± 2.4 14.2 ± 1.6 0.48
 Platelet, 103 /µL 254 ± 79 247 ± 72 0.22
 Total cholesterol, mg/dL 184 (55) 195 (57) 0.11
 LDL, cholesterol, mg/dL 124.8 ± -37.3 117.9 ± 36.7 0.04
Parametric variables are reported in mean ± SD or median (inter-quantile range); categorical variables are reported in number (percentage); BMI: Body Mass Index, CAD: Coronary Artery Disease, Post-PCI: Post-primary Coronary Intervention, EF: Ejection Fraction, HDL: High Density Lipoprotein, LDL: Low Density Lipoprotein
Table 1: Baseline characteristics, laboratory findings and clinical outcomes in STEMI patients according to the presence of metabolic syndrome.
Goto home»